Gday Babba. I think there are number of hurdles,
that will determine whether this is the real deal
or not.
1. Will the future P3 trials (002-003),(if they ever
get started) confirm the safety and efficacy of
iPPS?
2. Are the IP and agreement with Bene
watertight?
3. If we keep getting delay after delay after delay
will some other formulation claim the holy grail?
4. Can the company survive such a greedy,
incompetent management team?
Cheers.
Gday Babba. I think there are number of hurdles,that will...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 26.0¢ | 25.5¢ | $33.32K | 129.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15732 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 19048 | 4 |
View Market Depth
| Last trade - 10.27am 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
26.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 25.5¢ | 26.0¢ | 25.5¢ | 15066 | ||
| Last updated 11.02am 30/05/2024 ? | |||||
| PAR (ASX) Chart |